Soft Tissue Dermal Filler-Associated Necrosis and Impending Necrosis: A Systematic Review of the Literature

Dermatol Surg. 2022 Oct 1;48(10):1051-1056. doi: 10.1097/DSS.0000000000003574. Epub 2022 Sep 15.

Abstract

Background: Cosmetic soft tissue fillers are a popular minimally invasive procedure. Necrosis is a rare yet devastating complication of soft tissue fillers. To date, the relationship between soft tissue fillers and necrosis has not been fully described.

Objective: To systematically compile published cases of soft tissue fillers resulting in necrosis and collect data regarding the injection, treatment, and outcome.

Methods and materials: Using PRISMA protocol, a comprehensive search for soft tissue filler necrosis was performed using no time constraints, resulting in 97 articles encompassing 192 cases of soft tissue filler necrosis containing individual-level data.

Results: Of the cases analyzed, 66.1% had progressed to necrosis, whereas 33.9% of patients had impending necrosis. Necrosis most commonly resulted from injection of the nasolabial fold (32.4%, n = 88). The filler material most commonly used was hyaluronic acid (71.9%, n = 138). Hyaluronidase was used most frequently as an initial treatment agent (19.1%, n = 88). Forty-three patients (22.4%) with necrosis had a prior minor procedure or surgery.

Conclusion: This systematic review is an extensive overview of necrosis as a complication of soft tissue fillers. It serves as a reference tool for any clinician who injects soft tissue fillers and any provider who encounters soft tissue filler necrosis.

Publication types

  • Systematic Review

MeSH terms

  • Cosmetic Techniques* / adverse effects
  • Dermal Fillers* / adverse effects
  • Humans
  • Hyaluronic Acid / adverse effects
  • Hyaluronoglucosaminidase
  • Necrosis / chemically induced

Substances

  • Dermal Fillers
  • Hyaluronic Acid
  • Hyaluronoglucosaminidase